Dry SkinNCT07695805
Evaluation of the Effect of Combined Use of Cosmetic Products for Dry and Itchy Skin.
A study testing Shower oleogel and body lotion and Shower gel and body lotion in people with Dry Skin, run by Lacer S.A. at 1 site in Portugal.
Trial summary
The goal of this study is to learn if combined use of shower oleogel and body lotion works to improve skin itching and dryness in adults. It will also learn about its safety. The main question it aims to answer is: Does the products use improves skin hydration and itching? Researchers will compare shower oleogel and… Read more about this study
- Who is it for?
- Ages 18 to 70 yearsHealthy volunteers can take part
- Conditions the study is for
- Dry Skin
- What is being tested?
- Shower oleogel and body lotion and Shower gel and body lotion
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 sitePortugal
- Study dates
- Jul 2026to Sep 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age: 18-70 years old
- Gender: both
- Sensitive skin and 30% to 50% with atopic tendency (scored 8-12)
- With dry or very dry skin on the body
- With presence of itching due to different origins: contact/friction with fabrics, hard water, atopic tendency, dry skin, etc.
Who cannot join
- cutaneous marks on the experimental areas, which could interfere with the assessment of skin reactions (pigmentation troubles, scar elements, over-developed pilosity, ephelides and naevi in too great quantity, sunburn),
- allergy or reactivity to products of the same category than the tested one,
- with history of malignant melanomas (Dubreullh melanosis…)
- unbalanced hormonal treatment,
- forecast of initiation of an hormonal treatment or change of the usual hormonal treatment during the study or 3 months before the starting of the study,
- forecast of intensive sun or UVA exposure (UV lamps) during the test period,
Show all 17Show fewer
- breast-feeding or pregnancy,
- treatment with Vitamin A acid or its derivatives stopped less than 3 months before the beginning of the study,
- treatment with anti-stretch, firming, slimming or anti-cellulite products stopped less than 3 months before the beginning of the study,
- diet stopped less than 3 months before the beginning of the study,
- drugs likely to produce an increase or reduction in body weight,
- under anti-cellulite treatment: mesotherapy, electrotherapy, ionisation, ultrasonotherapy, relaxation, acupuncture, hydrotherapy, lymphatic drainage, massage, sauna,…,
- neither antibiotic, anti-allergic, anti-inflammatory treatment nor treatment with patent medicines containing Vitamin A acid or its derivatives before and during the study (if therapeutic requirement: exclusion foreseen),
- systemic disorders: Cardiovascular, pulmonary, digestive, neurologic, psychiatric, genital, urinary, haematological, endocrine
- individuals who have undergone a bilateral mastectomy with lymph node removal, a unilateral mastectomy with lymph node removal within the last year, or a bilateral axillary lymph node removal,
- individuals with a history of immune deficiency or auto-immune disease, treated for malignancy within 6 months prior to enrollment or who are currently under treatment for asthma or diabetes,
- forecast of vaccination during the test period or last vaccination within 3 weeks before the study
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Portugal1 site
PhD Trials
Lisbon, Lisbon District, 1750-182
Contreiras, +34 93 101 66 95, geral@phdtrials.com
About this study
Official title: Confirmation in Human Subjects of a Cosmetic Product Efficacy After Application in the Body Under Normal Conditions of Use.
The goal of this study is to learn if combined use of shower oleogel and body lotion works to improve skin itching and dryness in adults. It will also learn about its safety. The main question it aims to answer is:
- Does the products use improves skin hydration and itching? Researchers will compare shower oleogel and body lotion to a commercially available shower gel and the body lotion to see if the combined use is more efficient than use of body lotion alone.
Participants will:
- Use assigned products every day for 1 month
- Visit the CRO for checkups and tests on established schedule
- Conditions
- Dry Skin
- Being tested
- Shower oleogel and body lotion, Shower gel and body lotion
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Shower oleogel and body lotionOther
Daily use of shower oleogel and body lotion for 28 days
Shower gel and body lotionOther
Daily use of shower gel and body lotion
| Study group | Role | What they receive |
|---|---|---|
| shower oleogel and body lotion | Experimental | shower oleogel and body lotion will be used daily for 28 days Receives: Other: Shower oleogel and body lotion |
| shower gel and body lotion | Active comparator | shower gel and body lotion will be used daily for 28 days Receives: Other: Shower gel and body lotion |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change from Baseline in the rate of skin hydration (capacitance measured by Corneometer) at 4 weeks
Measured: From enrollment to the end of the study at 4 weeks
Secondary outcomes (1)
Change from Baseline in the rate of skin barrier function (TEWL evaluated by Tewameter) at 4 weeks.
Measured: From enrollment to the end of the study at 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Jul 2026
- Study startJul 2026 (estimated)
- Primary completionSep 2026 (estimated)
- Study completionSep 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Dry SkinStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Lacer S.A.
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Perdo Contreiras, Principal investigator, PhD Trials
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07695805
- Sponsor's protocol ID
- PhDES2851B
- Status last verified
- Jun 2026
- First submitted
- 1 Jul 2026
- Last updated
- 10 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Only summary of the results to support the publication will be shared. No complete study documents will be shared.
Study at a glance
From the registry record, last updated by the sponsor on 10 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Confirmation in Human Subjects of a Cosmetic Product Efficacy After Application in the Body Under Normal Conditions of Use.
- ClinicalTrials.gov ID
- NCT07695805
- Acronym / sponsor ID
- PhDES2851B
- Conditions
- Dry Skin
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Lacer S.A.Industry (pharma, biotech, devices)
- Study start
- Jul 2026 (estimated)
- Primary completion
- Sep 2026 (estimated)
- Study completion
- Sep 2026 (estimated)
- First posted
- 10 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this study is to learn if combined use of shower oleogel and body lotion works to improve skin itching and dryness in adults. It will also learn about its safety. The main question it aims to answer is:
- Does the products use improves skin hydration and itching? Researchers will compare shower oleogel and body lotion to a commercially available shower gel and the body lotion to see if the combined use is more efficient than use of body lotion alone.
Participants will:
- Use assigned products every day for 1 month
- Visit the CRO for checkups and tests on established schedule
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| shower oleogel and body lotion | Experimental | Other: Shower oleogel and body lotionshower oleogel and body lotion will be used daily for 28 days |
| shower gel and body lotion | Active comparator | Other: Shower gel and body lotionshower gel and body lotion will be used daily for 28 days |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Age: 18-70 years old
- Gender: both
- Sensitive skin and 30% to 50% with atopic tendency (scored 8-12)
- With dry or very dry skin on the body
- With presence of itching due to different origins: contact/friction with fabrics, hard water, atopic tendency, dry skin, etc.
Key exclusion criteria (17 listed)
- cutaneous marks on the experimental areas, which could interfere with the assessment of skin reactions (pigmentation troubles, scar elements, over-developed pilosity, ephelides and naevi in too great quantity, sunburn),
- allergy or reactivity to products of the same category than the tested one,
- with history of malignant melanomas (Dubreullh melanosis…)
- unbalanced hormonal treatment,
- forecast of initiation of an hormonal treatment or change of the usual hormonal treatment during the study or 3 months before the starting of the study,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Shower oleogel and body lotionDaily use of shower oleogel and body lotion for 28 days | Other | shower oleogel and body lotion |
| Shower gel and body lotionDaily use of shower gel and body lotion | Other | shower gel and body lotion |
Primary outcome
Change from Baseline in the rate of skin hydration (capacitance measured by Corneometer) at 4 weeks
Time frame: From enrollment to the end of the study at 4 weeks
1 secondary outcome
Change from Baseline in the rate of skin barrier function (TEWL evaluated by Tewameter) at 4 weeks.
Time frame: From enrollment to the end of the study at 4 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Jul 2026.
- Individual participant dataSharing planned: No. Only summary of the results to support the publication will be shared. No complete study documents will be shared.
Related trials for Dry Skin
Not yet recruitingPhase 1
R-2487 in Patients With Sjogren's Syndrome (SjD)
Sjogren's Syndrome, Sjögren
Not yet recruiting
Effect of Autologous Serum-Soaked Paper Patch vs. Traditional Dry Paper Patch on Tympanic Membrane Perforations
Tympanic Membrane Perforation
RecruitingPhase 1
A Trial in Healthy Adult Participants and Adults With Autoimmune Diseases to Test How HBM7020 is Tolerated and How it Behaves in the Body
Rheumatoid Arthritis, Systemic Lupus Erythematosus
RecruitingObservational study
Pain Phenotyping of Rheumatic Diseases - An Observational Study
Rheumatic Diseases, Lupus Erythematosus, Systemic
RecruitingPhase 1/2
Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration
Dry Age-Related Macular Degeneration, Geographic Atrophy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Perdo Contreiras principal investigator
PhD Trials
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Shower oleogel and body lotion and Shower gel and body lotion in people with Dry Skin, run by Lacer S.A. at 1 site in Portugal.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 10 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Contreiras (+34 93 101 66 95, geral@phdtrials.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change from Baseline in the rate of skin hydration (capacitance measured by Corneometer) at 4 weeks (time frame: From enrollment to the end of the study at 4 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jul 2026.